Tenon Medical, Inc.

8-K Shareholder vote results Jul 24, 2026 8-K Other events Jul 20, 2026 8-K Other events Jul 10, 2026 8-K Entered a material agreement; Other events Jul 2, 2026 8-K Entered a material agreement; Director or officer change Jun 12, 2026 8-K Amended charter or bylaws Jun 11, 2026 8-K Delisting notice or listing-rule failure May 22, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 17, 2026 8-K Delisting notice or listing-rule failure Feb 27, 2026 8-K Results of operations (earnings release); Other events Feb 6, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K/A AMENDMENT NO. 1 TO FORM 8-K Oct 17, 2025 8-K Unregistered sale of equity Oct 16, 2025 8-K Shareholder vote results Sep 23, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Aug 7, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 12, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Delisting notice or listing-rule failure Oct 4, 2024 8-K Entered a material agreement; Regulation FD disclosure Sep 17, 2024 8-K Entered a material agreement; Unregistered sale of equity Sep 16, 2024 8-K Delisting notice or listing-rule failure Sep 11, 2024 8-K/A Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws Sep 10, 2024 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity Sep 6, 2024 8-K Director or officer change; Other events Aug 27, 2024 8-K Delisting notice or listing-rule failure Aug 26, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Shareholder vote results Jul 25, 2024 8-K Director or officer change May 22, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Delisting notice or listing-rule failure May 8, 2024